ChemoMetec A/S (CPH:CHEMM)
609.50
-1.00 (-0.16%)
At close: Jan 30, 2026
ChemoMetec Market Cap
ChemoMetec has a market cap or net worth of 10.61 billion as of January 30, 2026. Its market cap has increased by 19.04% in one year.
Market Cap
10.61B
Enterprise Value
10.27B
Revenue
495.57M
Ranking
n/a
PE Ratio
56.91
Stock Price
609.50
Market Cap Chart
Since December 18, 2006, ChemoMetec's market cap has increased from 374.48M to 10.61B, an increase of 2,732.38%. That is a compound annual growth rate of 19.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 10.61B | -11.35% |
| Dec 30, 2025 | 11.96B | 41.40% |
| Dec 30, 2024 | 8.46B | 25.31% |
| Dec 29, 2023 | 6.75B | -43.81% |
| Dec 30, 2022 | 12.02B | -17.11% |
| Dec 30, 2021 | 14.50B | 44.12% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.65T |
| Genmab | 127.33B |
| Coloplast | 122.01B |
| Demant | 46.82B |
| H. Lundbeck | 40.25B |
| Zealand Pharma | 29.01B |
| Ambu A/S | 22.59B |
| GN Store Nord | 15.76B |